{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"FDA Approves Axsome\u2019s New Migraine Drug Symbravo\u00ae","description":"The FDA has approved a new drug for the acute treatment of migraine with or without aura in adults. Molly O\u2019Brien has the details and when it becomes available in this Migraine Minute News update.&amp;nbsp; &amp;nbsp; Learn More:  https:\/\/axsometherapeuticsinc.gcs-web.com\/news-releases\/news-release-details\/axsome-therapeutics-announces-fda-approval-symbravor-meloxicam ","author_name":"Migraine Minute News Update","author_url":"http:\/\/migraineminute.libsyn.com\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/35952450\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/256d9f\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/35952450"}